Xinhua

Argentine residents protest against biotechnology company "Monsanto" Xinhua Residents attend a protest in front of the headquarters of the company "Monsanto", specialized on biotechnology, in the city of Buenos Aires, capital of Argentina, May 25, 2013. On Saturday, Argentine residents joined the international "World March ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNF_dPRQklDkWAnZLOoySOBqq4O42A&url=http://news.xinhuanet.com/english/photo/2013-05/26/c_132408612.htm

Anti-Monsanto crowd takes to the streets in Rockland to protest genetically ... Bangor Daily News But Benildo de los Reyes, a University of Maine molecular genetics professor, said that it is frustrating that many people have such negative views about science that they don't fully understand. “A very powerful tool is being wasted because of ... and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHA_-LVZ0rEDT6IRSOB1PCrTugqNA&url=http://bangordailynews.com/2013/05/25/news/midcoast/anti-monsanto-crowd-takes-to-the-streets-in-rockland-to-protest-genetically-modified-seeds/

Stem Cell Therapy Worldwide
http://www.placidway.com/ - Looking for best and affordable stem cell therapy? Placidway offers best and most affordable stem cell therapy with the top docto...

By: placidways #39;s channel

More:
Stem Cell Therapy Worldwide - Video

LaViv stem cell therapy for acne scars
Dermatologist and cosmetic surgeon Dr. Melanie Palm of http://www.artofskinmd.com discusses and demonstrates the use of LaVIV, the first available personalized stem...

By: melaniepalm

See more here:
LaViv stem cell therapy for acne scars - Video

(MENAFN - AFP) Italian lawmakers on Wednesday gave their final approval to a law that allows limited use of a controversial type of stem cell therapy which has been condemned by many scientists but has given hope to families of terminally-ill children.

The law gives the go-ahead for therapy being carried out by the Stamina Foundation on dozens of patients to continue, and allows for an 18-month period of clinical trials for the procedure, which had previously been blocked by Italian authorities.

The bill was amended from an earlier version and states the therapy must be carried out under regulatory oversight and using cells made according to the Good Manufacturing Practice (GMP) which the Stamina Foundation has not adhered to.

The Stamina Foundation says its treatment is based on mesenchymal stem cells and could treat diseases like spinal cord injury and motor neurone disease.

But leading scientists have warned that there is no evidence to suggest the treatment could work and no way to know that it will not cause harm.

Patients lobbied for the therapy to be given the go-ahead, receiving support from various celebrities including actress Gina Lollobrigida.

At one demonstration, protesters wore T-shirts with the slogan: "Yes to Stamina, Yes to Life".

The association Stem Cell Research Italy has branded the new law as "unacceptable" saying the therapy was not backed up by clinical data published in peer-reviewed academic journals.

US journal Nature said it was a "rogue" therapy.

Read the original:
Italy approves controversial stem cell therapy

Italian lawmakers on Wednesday gave their final approval to a law that allows limited use of a controversial type of stem cell therapy which has been condemned by many scientists but has given hope to families of terminally-ill children.

The law gives the go-ahead for therapy being carried out by the Stamina Foundation on dozens of patients to continue, and allows for an 18-month period of clinical trials for the procedure, which had previously been blocked by Italian authorities.

The bill was amended from an earlier version and states the therapy must be carried out under regulatory oversight and using cells made according to the Good Manufacturing Practice (GMP) which the Stamina Foundation has not adhered to.

The Stamina Foundation says its treatment is based on mesenchymal stem cells and could treat diseases like spinal cord injury and motor neurone disease.

But leading scientists have warned that there is no evidence to suggest the treatment could work and no way to know that it will not cause harm.

Umberto Galderisi from the University of Naples and president of Stem Cell Italy, is among critics of the bill.

He said the clinical trials would "never have been allowed" if scientific accepted practice had been followed.

"This is legislating on the basis of public opinion. It means exploiting suffering. Patients are not lab rats," he told AFP, adding there were "no scientific certainties" the therapy could work.

"We do not want Italy to become one of those countries like China or Ukraine where there are untested scientific trials," he said.

Patients lobbied for the therapy to be given the go-ahead, receiving support from various celebrities including actress Gina Lollobrigida.

Excerpt from:
Italy approves law on controversial stem cell therapy

CLEARWATER, Fla., May 20, 2013 /PRNewswire/ -- Sports Medicine is always at the forefront of innovative medical technology. Athletes are constantly striving to improve. Records are broken as humans run faster, jump higher, and strive for higher levels of performance. Athletes expose their bodies to more wear and tear as performance increases. Scientific training principles and diet have changed drastically over time. Technological breakthroughs have also impacted the rehabilitation process. The use of regenerative medicine has grown significantly in recent years. The popularity of Platelet-Rich-Plasma (PRP) has escalated as many high profile elite athletes from a diverse array of sports have opted for this treatment. The likes of Kobe Bryant, Rafael Nadal, and Tiger Woods garner ample press coverage when they are treated for injuries. Stem Cell Therapy becomes headlines when Peyton Manning undergoes this treatment. The goal of regenerative medicine therapies is to aid the body to heal itself. Understanding and accepting stem cell therapies for athletic injuries and sports medicine is gathering keen interest.

Dr. Dennis Lox, http://www.drlox.com a Sports and Regenerative Medicine Physician in the Tampa Bay Florida area, comments that the scientific backdrop of cell signaling and inflammatory mediators has led to a new understanding of how tissues heal. This also explains why injured tissues fail to heal, and is why the aging athlete recovers and heals more slowly than his younger counterpart. It is felt that the use of growth factors in Platelet-Rich-Plasma (PRP) is a localized cellular response to control negative repair processes and direct healing toward a positive restorative pathway. This directional approach to control repair, is more complex in stem cells, and as such, may be more effective for healing injured tissue. The stem cells are the body's repair cells that direct the necessary patterns of cellular messenger signals to target the repair process. It is not a simple chemical reaction where two chemicals react and one outcome results. There are a myriad of complicated molecules that interact to direct the repair process, and to counter the effects of a multitude of other molecules and signals regulating the breakdown or degradation of tissue. Dr. Lox points out, it is overcoming the many undesirable messages that occur with injury, whereby regenerative medicine may enhance sports injury recovery. Athletes are in need of rapid recovery to avoid losing peak conditioning. Aging athletes do not heal as effectively. Finding successful measures to aid the body in the healing naturally, is desirable for athletes and in preventing degenerative arthritis. Understanding the scientific rationale for the use of Platelet-Rich-Plasma (PRP) and Stem Cell Therapy, may pave the way for the expansive role for these treatments in future directions for athletic injury.

About Dr. Dennis Lox Dr. Lox practices in the Tampa Bay Florida area. Dr. Lox is a Sports and Regenerative Medicine Physician, who specializes in the use of regenerative and restorative medicine to assist in treating athletic and arthritis conditions. Dr. Lox may be reached at (727) 462-5582 or visit Drlox.com.

Read the original:
Sports Medicine New Frontiers: Platelet-Rich-Plasma (PRP) and Stem Cell Therapy

Treatment of a patient with Parkinson #39;s Disease using stem cell therapy
Here we demonstrate how a patient who suffers from Parkinson #39;s Disease has benefited from stem cell therapy with us in Panama.

By: SCRMPanama

Read the rest here:
Treatment of a patient with Parkinson's Disease using stem cell therapy - Video

Ellen Jorgensen is dragging genetic engineering away from the scare stories Wired.co.uk Biohackers are rare -- costs have kept genetic engineering in the realm of big pharma and university labs. But Ellen Jorgensen, a PhD molecular biologist, sees a tipping point: "You can sequence genes on a computer, email them to a lab and a week later ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEueTj0X6wQ6S7SdnkFqVPL8JjwLQ&url=http://www.wired.co.uk/magazine/archive/2013/05/start/trust-me-im-a-friendly-biohacker

Progenics Pharmaceuticals Added to the NASDAQ Biotechnology Index NASDAQ The NASDAQ Biotechnology Index is designed to track the performance of a set of NASDAQ Stock Market-listed securities classified according to the Industry Classification Benchmark (ICB) as either Biotechnology or Pharmaceuticals. The NASDAQ ... NASDAQ Biotechnology Index surpasses all-time high in 1Q13Lexology (registration) all 2 news articles »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHYyTGnOh2e1g-4dyI4ndfaN4UdRg&url=http://www.nasdaq.com/article/progenics-pharmaceuticals-added-to-the-nasdaq-biotechnology-index-20130517-00625

State to market growing biotechnology industry al.com BIRMINGHAM, Alabama – Alabama's burgeoning biotech industry, with about 550 companies statewide, has to a degree escaped the notice of the world, Alabama Secretary of Commerce Greg Canfield said today. The state intends to change that.

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFjyGmPq4qbx1I8_XnhAaa-Y1pJeg&url=http://www.al.com/business/index.ssf/2013/05/state_to_market_growing_biotec.html

Medill Reports: Chicago

Teachers become the students at biotechnology symposium Medill Reports: Chicago Chicago area high school students will spend less time at their desks next fall after their science teachers attended the second annual Biotechnology Symposium Tuesday at Northwestern University. The conference and upcoming summer development series ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGr7t_Hs7oyayUx6CT4fZkgrAFG7A&url=http://news.medill.northwestern.edu/chicago/news.aspx?id%3D221559

NewLink Genetics to Be Added to NASDAQ Biotechnology Index - Marketwire Marketwire (press release) The NASDAQ Biotechnology Index is designed to track the performance of a set of NASDAQ-listed securities classified according to the Industry Classification Benchmark (ICB) as either Biotechnology or Pharmaceuticals. These companies must meet ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFtDM3j3S_hkfSuVSRa_vLt9RWp9Q&url=http://www.marketwire.com/press-release/newlink-genetics-to-be-added-to-nasdaq-biotechnology-index-nasdaq-nlnk-1791789.htm

Channel News Asia

Clinical testing of Singapore's first influenza vaccine starts Channel News Asia Singapore's first healthy volunteer has been given a dose of the H1N1 influenza vaccine developed by Singapore's A*STAR and Switzerland's Cytos Biotechnology AG in a clinical trial. PHOTOS. A medical technician performs tests for viruses (AFP) ... First influenza vaccine brought to clinical testing - Medical XpressMedical Xpress Singapore's first H1N1 flu vaccine starts clinical testXinhua A*Star and Cytos advance Singapore's first flu vaccinePharmaTimes all 6 news articles »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNETu17oac0pDp-PihplnQEFRmsnCg&url=http://www.channelnewsasia.com/news/singapore/clinical-testing-of-singapore-s-first-in/678518.html

Sony Biotechnology Inc.'s New Technology for Science Provides Researchers ... PR Newswire (press release) CHAMPAIGN, Ill., May 17, 2013 /PRNewswire/ -- Sony Biotechnology Inc. ("Sony") today announced the launch of the new Sony SP6800 Spectral Analyzer (SP6800). Sony will be exhibiting and taking orders for this system at CYTO 2013, which will be held at ... Sony Delivers New Technology for Science to CYTO 2013International Business Times (press release) all 2 news articles »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNE7QEfjJEcHXTiSReQOVgVD0ysJEQ&url=http://www.prnewswire.com/news-releases/sony-biotechnology-incs-new-technology-for-science-provides-researchers-results-in-color-207864031.html

Daily Beast

Bowman decision affirms future of seed biotechnology Delta Farm Press The TheTThe The???? In a 9-0 ruling, the Supreme Court rejected soybean farmer Vernon Bowman's claim that he was within his rights to plant Monsanto's Roundup Ready soybeans without the company's approval. The decision upholds Monsanto's seed ... Supreme Court unanimously upholds patent-holders rights in agricultural ...Lexology (registration) Supreme Court Holds That Exhaustion Doctrine Does Not Permit Purchasers Of ...Mondaq News Alerts (registration) Supreme Court Sides with Monsanto on Issue of Patent Protection for ...The National Law Review agprofessional.com all 50 news articles »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFi2C6V648NRNiDHzQwxHgMqbBn8Q&url=http://deltafarmpress.com/government/bowman-decision-affirms-future-seed-biotechnology

PUMA BIOTECHNOLOGY INC : Puma Biotechnology Comment on Trading Activity 4-traders (press release) Puma Biotechnology, Inc. (NYSE: PBYI), a development stage biopharmaceutical company, has been contacted by the New York Stock Exchange regarding today's trading in the Company's common stock. It is the Company's policy not to comment on trading ... Puma Biotech Gains After Rival Drug Data Show No ThreatBloomberg all 2 news articles »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNE7fDG5rIuh7xj167D4xJx_J49YKQ&url=http://www.4-traders.com/PUMA-BIOTECHNOLOGY-INC-11782372/news/Puma-Biotechnology-Inc-Puma-Biotechnology-Comment-on-Trading-Activity-16870555/

PR Web (press release)

Sanford Research Team Discovers Promising Batten Disease Therapy - PRWeb PR Web (press release) A team from Sanford Research has discovered a potentially promising therapy for reducing the degenerative effects of Batten disease, according to a recent study published by Human Molecular Genetics. Sanford Research's Jake Miller, Chun-Hung Chan, ... and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFRY9E39AnErcvlBV8Lp5VcKZ_OSw&url=http://www.prweb.com/releases/2013/5/prweb10718454.htm

Discovery Institute

Term Limits: Eugenie C. Scott and the Retirement of "Darwinism" Discovery Institute Dragutin Savic is professor of Molecular Genetics at the Faculty of Sciences, University of Belgrade. He spent several years as a visiting scientist at Johns Hopkins University, Carolinska Institute and Institute J. Monod. This article considers ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFdZfBPq7F_ApWov0-BW6-B83_4WA&url=http://www.evolutionnews.org/2013/05/term_limits_eug072281.html

Sisters increase awareness of hereditary breast cancer Richmond Times Dispatch “As much as we try to be science-based, there's not a real clear algorithm that says this is the path you should take,” said John Quillin, an assistant professor of human and molecular genetics at VCU Massey Cancer Center and a genetic counselor in the ... and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNF3wX_XWXJmnX2RlQJXI4oQl0J5PA&url=http://www.timesdispatch.com/business/health/article_be3ec948-5181-501c-a3cd-fb004949d49b.html